Positive Airway Pressure Devices Market To Reach $7.40 Billion By 2033

Positive Airway Pressure Devices Growth & Trends

The global positive airway pressure devices market size is expected to reach USD 7.40 billion by 2033, registering a CAGR of 5.48% from 2026 to 2033, according to a new report by Grand View Research, Inc. The healthcare industry is facing challenges owing to the rapidly growing prevalence of obstructive sleep apnea and sleep apnea-associated chronic comorbidities. Obstructive sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. As per the global prevalence of obstructive sleep apnea estimates published in June 2022 by UpToDate, over 936 million individuals across the globe suffer from mild to severe sleep apnea.

Changing lifestyles owing to globalization and the adoption of unhealthy dietary habits are making individuals prone to obesity, Cardiovascular Diseases (CVDs), diabetes, and hypertension, which are forerunners of obstructive sleep apnea. As per the estimates published by the World Population Review, 36.2% of the U.S. population is diagnosed as obese. In addition, the rapidly increasing geriatric population coupled with increasing life expectancy is anticipated to contribute to the incidence rate of obstructive sleep apnea and directly drive the demand for positive airway pressure devices (PAP) devices. The COVID-19 pandemic restrained the growth of the market owing to multiple lockdowns and travel restrictions imposed by governments across the globe to curb the transmission rate.

In addition, the postponement of elective procedures and infrastructural changes in healthcare facilities to accommodate COVID-19 care facilities negatively impacted the procedural volume, which hindered market growth. Healthcare facilities and sleep centers recorded a declining trend in diagnostic and therapeutic procedural volume, restricting the growth of PAP devices. The American Academy of Sleep Medicine (AASM) introduced protocols to adopt virtual consultations to address the declining sleep studies volume. However, during the initial months of the pandemic, PAP machines were being used as the first line of treatment and as an alternative to ventilators in mechanical ventilation. Global government bodies are devising strategies to promote awareness levels among the population and promote the adoption of PAP machines. The availability of favorable reimbursement policies is further boosting product adoption.

 Request a free sample copy or view report summary: Positive Airway Pressure Devices Market Report

Positive Airway Pressure Devices Market Report Highlights

• For instance, in January 2025, ResMed introduced the AirSense 11 CPAP device in India, adding features like Personal Therapy Assistant and Care Check-In along with AirView and myAir connectivity to support higher adherence and ease patients into sleep apnea treatment.

• For instance, in December 2025, the FDA granted clearance to ResMed’s AI-enabled Smart Comfort digital medical device, highlighting the growing regulatory scrutiny and acceptance of advanced, personalized therapy solutions.

• Regional expansion is high, particularly in emerging markets such as Asia Pacific and Latin America. As awareness of sleep disorders increases, companies target these regions for growth opportunities.

• Despite these findings, the impact of GLP-1 drugs on the Positive Airway Pressure (PAP) devices market is expected to be nuanced. As per the Informa Markets, May 2024 studies, some analysts suggest that while GLP-1 therapies may reduce the incidence of OSA by promoting weight loss, they could also increase awareness and diagnosis of sleep apnea, potentially leading to higher demand for PAP devices

• The Continuous Positive Airway Pressure (CPAP) devices segment dominated the market with a share of 57.4% in 2025. This can be attributed to the rising prevalence of sleep apnea, particularly obstructive sleep apnea (OSA), which has significantly increased the demand for CPAP devices as the primary treatment option

• The Obstructive Sleep Apnea segment held the largest market share in 2025. The rising prevalence of Obstructive Sleep Apnea (OSA), which is estimated to affect millions worldwide, is an effective driver for this market

• The Chronic Obstructive Pulmonary Disease (COPD) segment drives the demand for PAP devices. COPD, a group of lung diseases including emphysema and chronic bronchitis, is characterized by long-term respiratory issues, making it difficult for patients to breathe

• The hospitals and clinics segment dominated the market in 2025, driven by the increasing prevalence of sleep apnea and the rising demand for professional diagnosis and treatment

• North America dominated the market and accounted for a 51.39% share in 2025. North America positive airway pressure devices market is witnessing substantial growth

Positive Airway Pressure Devices Market Segmentation

Grand View Research has segmented the global positive airway pressure devices market report based on product, application, end use, and region:

Positive Airway Pressure Devices Product Outlook (Volume, 000` Units; Revenue, USD Million, 2021 - 2033)

• CPAP

  • Connected

    • Bluetooth-Connected CPAP

    • Wi-Fi & Cellular Connected CPAP

    • Hybrid-Connected

  • Non-Connected

• APAP

• Bi-PAP

Positive Airway Pressure Devices Application Outlook (Volume, 000`Units; Revenue, USD Million, 2021 - 2033)

• Obstructive Sleep Apnea

• Respiratory Failures

• COPD

Positive Airway Pressure Devices End Use Outlook (Volume, 000`Units; Revenue, USD Million, 2021 - 2033)

• Home Care Settings

• Hospitals & Clinics

• Others (Long-Term Care Facilities, etc.)

Positive Airway Pressure Devices Regional Outlook (Volume, 000`Units; Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

List of Key Players in Positive Airway Pressure Devices Market

• Koninklijke Philips N.V.

• SEFAM

• Trudell Medical (Vyaire)

• Löwenstein Medical UK Ltd

• Transcend Inc. (Somnetics International, Inc.)

• Fisher & Paykel Healthcare Limited

• ResMed

• Drive DeVilbiss Healthcare

• React Health (3B Medical)

• BMC Medical

• Armstrong Medical Inc.

• Wellell (Apex Medical)

• Breas Medical